A Study to Evaluate Immunotherapy Combinations in Participants With Lung Cancer

Clinical trial NCT03846310 · COMPLETED

Trial details

NCT number: NCT03846310
Sponsor: Arcus Biosciences, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Metastatic Non Small Cell Lung Cancer Nonsquamous Nonsmall Cell Neoplasm of Lung Sensitizing EGFR Gene Mutation

Start date: 2019-04-01
Primary completion: 2024-11-18
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.